The Diversity of Bartonellosis Manifestations and Challenges to Treatment

Activity Title

The Diversity of Bartonellosis Manifestations and Challenges to Treatment

Description

Human Bartonellosis is an underappreciated public health problem. Like Lyme disease, Bartonellosis can be difficult to recognize clinically, to diagnose empirically, and to treat effectively. Bartonella bacteria cause systemic infections due to their broad organ tropism, which can manifest with a wide variety of signs and symptoms. While severe complications are typically associated with an immunocompromised state, neurological disease and association with tick-borne coinfection morbidity, without prior immune compromise, are becoming more apparent. Given the ability of this pathogen to invade multiple cell types and tissues, antibiotic treatment must have good cellular penetration, and no single treatment is known to be effective against all Bartonella-associated diseases.

This activity is intended to provide the following information about Bartonella infection.

Pathogen transmission
Disease manifestations
Diagnosis and Treatment
Possible misdiagnosis and co-infections
Research needs and unanswered questions

Intended Audience

Clinicians, including infectious disease and internal medicine specialists, psychiatrists, and dermatologists, clinical laboratories, emergency room and urgent care centers and any other allied health professionals or patients interested in learning about human Bartonellosis.

Learning Objectives

1. Describe the possible clinical presentations (signs and symptoms) of Bartonellosis.
2. Compare Bartonellosis to Lyme borreliosis in terms of detection, persistence and treatment.
3. Identify research efforts needed to better diagnose and cure Bartonellosis.

Speaker

Monica E. Embers, Ph.D.
Associate Professor
Microbiology and Immunology
Director of Vector-Borne Disease Research
Tulane University
National Primate Research Center

Duration

0.5 hour

Release and Expiration Dates

Release Date: January 8, 2024
Expiration Date: January 8, 2026

Disclosures

The opinions expressed in the educational activity are those of the speaker and do not necessarily represent the views of any organization associated with this activity.

Monica E. Embers, Ph.D.
- Nothing to disclose

P.A.C.E. Accreditation

Quidel is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.^® Program.

Policy on Privacy and Confidentiality

Quidel Corporation protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Quidel Corporation and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Quidel Corporation and its educational partners maintain physical, electronic and procedural safeguards that comply with recognized accreditation regulations to guard your non-public personal information.

Medium Used

This program has been made available online.

Commercial Support Statement

This activity is provided by the Quidel Corporation.

System Requirements

To view this educational activity you will need a modern web browser with JavaScript and HTML5. Cookies enabled allows users to proceed through all elements. Some users encounter issues with hand held devices ie. smart phones. In these cases we recommend the use of computers.
IMPORTANT NOTE: Internet Explorer is no longer officially supported by the manufacturer, and functionality and vulnerability issues have been reported. Please avoid the use of Internet Explorer.

Activity Title